Inactive Instrument

Other languages Opsens Inc.

Equities

OPS

CA6838231083

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Haemonetics Completes $255 Million Acquisition of OpSens	Dec. 12
Haemonetics Corporation (NYSE : HAE) completed the acquisition of Opsens Inc. (TSX : OPS).	Dec. 11
Opsens Shareholders Approve Arrangement With Haemonetics	Dec. 01
Opsens Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	Nov. 22
OpSens Fiscal Q4 Loss Narrows as Sales Rise 57% Ahead of Acquisition by Haemonetics	Nov. 22
Opsens Inc. Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	Nov. 21
Opsens Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	23-07-13
OpSens Reports Q3 Consolidated Revenue of $13.2 Million; Net Loss of $0.04 Per Diluted Share	23-07-13
OpSens Inc. Announces Inclusion of Savvywire™ in COMPLETE TAVR Study	23-05-10
Opsens Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	23-04-13
OpSens Reports Q2 Revenue of $10.8 Million	23-04-13
Opsens Announces Completion of Enrollment in Safe-Tavi Study with Savvywire® in Europe	23-04-11
Opsens Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23-01-12
OpSens Q1 Reports Net loss of $0.03 Per Share, Sales up 26% YoY	23-01-12
Opsens Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	22-11-22
OpSens Reports Q4 Revenue up 12% to $9.1 Million; Net Loss of $0.04 Per Share	22-11-22
Opsens Inc. Announces Departure of Robin Villeneuve as Corporate Secretary, Effective December 9, 2022	22-11-01
Opsens Inc. Announces First Savvywire Clinical Cases in Europe and Launch of Safe-Tavi Study	22-10-26
Opsens Announces First Savvywire Procedure in the United States by Dr. Philippe Genereux of Morristown Medical Center	22-09-23
OpSens Inc. Announces FDA Clearance for the SavvyWire for Use in Transcatheter Aortic Valve Replacement Procedures	22-09-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Opsens Inc.

Equities

OPS

CA6838231083

Other languages

Filters